Rpg Investment Advisory, LLC Biomarin Pharmaceutical Inc Transaction History

Rpg Investment Advisory, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$77.67 - $92.63 $1.33 Million - $1.59 Million	-17,160 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $24,228 - $28,539	-300 Reduced 1.72%	17,160 $1.53 Million
Q3 2017 Feb 05, 2019	SELL	$80.6 - $94.95 $1,612 - $1,899	-20 Reduced 0.11%	17,460 $1.63 Million
Q2 2017 Feb 04, 2019	BUY	N/A	17,480	17,480 $1.59 Million

626

183M

1.67M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Rpg Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Rpg Investment Advisory, LLC with notifications on news.